BACKGROUND: Early-life exposures to tobacco smoke and some dietary factors have been identified to induce epigenetic changes in genes involved in allergy and asthma development. Omega-3 (n-3) polyunsaturated fatty acid (PUFA) intake during pregnancy could modulate key cytokines and T helper (Th) cell maturation; however, little is known about the mechanism by which ω-3 PUFA could have a beneficial effect in preventing inflammatory disorders. OBJECTIVE: We sought to test whether prenatal dietary supplementation with ω-3 PUFA during pregnancy may modulate epigenetic states in the infant immune system. DESIGN: This study was based on a randomized intervention trial conducted in Mexican pregnant women supplemented daily with 400 mgdocosahexaenoic acid (DHA) or a placebo from 18 to 22 wk of gestation to parturition. We applied quantitative profiling of DNA methylation states in Th1, Th2, Th17, and regulatory T-relevant genes as well as LINE1 repetitive elements of cord blood mononuclear cells (n = 261). RESULTS: No significant difference in promoter methylation levels was shown between ω-3 PUFA-supplemented and control groups for the genes analyzed; however, ω-3 PUFA supplementation was associated with changes in methylation levels in LINE1 repetitive elements (P = 0.03) in infants of mothers who smoked during pregnancy. Furthermore, an association between the promoter methylation levels of IFNγ and IL13 was modulated by ω-3 PUFA supplementation (P = 0.06). CONCLUSIONS: Our results indicate that maternal supplementation with ω-3 PUFA during pregnancy may modulate global methylation levels and the Th1/Th2 balance in infants. Therefore, the epigenetic mechanisms could provide attractive targets for prenatal modulation and prevention of inflammatory disorders and potentially other related diseases in childhood and adulthood.
RCT Entities:
BACKGROUND: Early-life exposures to tobacco smoke and some dietary factors have been identified to induce epigenetic changes in genes involved in allergy and asthma development. Omega-3 (n-3) polyunsaturated fatty acid (PUFA) intake during pregnancy could modulate key cytokines and T helper (Th) cell maturation; however, little is known about the mechanism by which ω-3 PUFA could have a beneficial effect in preventing inflammatory disorders. OBJECTIVE: We sought to test whether prenatal dietary supplementation with ω-3 PUFA during pregnancy may modulate epigenetic states in the infant immune system. DESIGN: This study was based on a randomized intervention trial conducted in Mexican pregnant women supplemented daily with 400 mg docosahexaenoic acid (DHA) or a placebo from 18 to 22 wk of gestation to parturition. We applied quantitative profiling of DNA methylation states in Th1, Th2, Th17, and regulatory T-relevant genes as well as LINE1 repetitive elements of cord blood mononuclear cells (n = 261). RESULTS: No significant difference in promoter methylation levels was shown between ω-3 PUFA-supplemented and control groups for the genes analyzed; however, ω-3 PUFA supplementation was associated with changes in methylation levels in LINE1 repetitive elements (P = 0.03) in infants of mothers who smoked during pregnancy. Furthermore, an association between the promoter methylation levels of IFNγ and IL13 was modulated by ω-3 PUFA supplementation (P = 0.06). CONCLUSIONS: Our results indicate that maternal supplementation with ω-3 PUFA during pregnancy may modulate global methylation levels and the Th1/Th2 balance in infants. Therefore, the epigenetic mechanisms could provide attractive targets for prenatal modulation and prevention of inflammatory disorders and potentially other related diseases in childhood and adulthood.
Authors: Allen S Yang; Marcos R H Estécio; Ketan Doshi; Yutaka Kondo; Eloiza H Tajara; Jean-Pierre J Issa Journal: Nucleic Acids Res Date: 2004-02-18 Impact factor: 16.971
Authors: Janet A Dunstan; Trevor A Mori; Anne Barden; Lawrence J Beilin; Angie L Taylor; Patrick G Holt; Susan L Prescott Journal: J Allergy Clin Immunol Date: 2003-12 Impact factor: 10.793
Authors: Julie Rowe; Tricia Heaton; Merci Kusel; Devinda Suriyaarachchi; Michael Serralha; Barbara J Holt; Nick de Klerk; Peter D Sly; Patrick G Holt Journal: J Allergy Clin Immunol Date: 2004-04 Impact factor: 10.793
Authors: M A Norman; E A Holly; D K Ahn; S Preston-Martin; B A Mueller; P M Bracci Journal: Cancer Epidemiol Biomarkers Prev Date: 1996-02 Impact factor: 4.254
Authors: Carmen J Marsit; Sean S Brummel; Deborah Kacanek; George R Seage; Stephen A Spector; David A Armstrong; Barry M Lester; Kenneth Rich Journal: Epigenetics Date: 2015 Impact factor: 4.528
Authors: Elizabeth Cole; Traci A Brown; Kent E Pinkerton; Britten Postma; Keegan Malany; Mihi Yang; Yang Jee Kim; Raymond F Hamilton; Andrij Holian; Yoon Hee Cho Journal: Inhal Toxicol Date: 2017-08 Impact factor: 2.724
Authors: Guillermo A Silva-Martínez; Dalia Rodríguez-Ríos; Yolanda Alvarado-Caudillo; Alejandro Vaquero; Manel Esteller; F Javier Carmona; Sebastian Moran; Finn C Nielsen; Marie Wickström-Lindholm; Katarzyna Wrobel; Kazimierz Wrobel; Gloria Barbosa-Sabanero; Silvio Zaina; Gertrud Lund Journal: Epigenetics Date: 2016-04-18 Impact factor: 4.528
Authors: Manori Amarasekera; Paul Noakes; Deborah Strickland; Richard Saffery; David J Martino; Susan L Prescott Journal: Epigenetics Date: 2014-12 Impact factor: 4.528